ABC120mg+3TC60mg disp. tabs/PAC-60

General Description
Abacavir Sulfate equivalent to 120mg Abacavir + Lamivudine 60mg dispersible tablet, bottle pack of 60. Product may come with or without outer carton.

Technical Specifications
Each dispersible tablet contains Abacavir Sulfate equivalent to 120mg Abacavir plus Lamivudine 60mg.

Therapeutic class
Abacavir and Lamivudine are nucleoside reverse transcriptase inhibitors (NRTI).

Shelf life:
24 months

Storage and transportation:
Do not store above 25ºC
This product MUST be transported between +15ºC to +25ºC unless specified otherwise.

Dosage, Instructions for use:
Please refer to the guideline WHO Model Formulary 2008:
http://apps.who.int/iris/bitstream/handle/10665/44053/9789241547659_eng. pdf?sequence=1
https://www.who.int/publications/i/item/9789241547659
For more details, please see WHO treatment guidelines https://www.who.int/publications/i/item/9789240031593 and WHO Essential Medicines Library https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02 or your regional/national guidelines.

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Dispensing instructions
Dispense in original container. Do not repack

Component of a Kit
This item is a component of S9901023 - IEHK2017, PEP kit (S1400643- ABC120mg+3TC60mg disp. tabs/PAC-60 gb)

Alternative Product
S1400642ABC120mg+3TC60mg disp. tabs/PAC-30 gb
S1400643ABC120mg+3TC60mg disp. tabs/PAC-60 gb
S1400692ABC120mg+3TC60mg disp. tab/PAC-30 No CTN
S1400693ABC120mg+3TC60mg disp. tab/PAC-60 No CTN

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.